BIAF
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$15.27
+19.48%Margins
Gross margin
-39.6%
EBITDA margin
-249.5%
EBIT margin
-209.8%
Net margin
-257.3%
FCF margin
-194.9%
-402.9%
Return on equity
-199.3%
Return on assets
-237.9%
Return on invested capital
0.76x
Asset turnover
-$11.5M
Cash from operations
$4.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026